Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Author: Gibson, C. Michael MS, MD; Pinto, Duane S. MD, MPH; Chi, Gerald MD; Arbetter, Douglas MPH; Yee, Megan MPH; Mehran, Roxana MD; Bode, Christoph MD; Halperin, Jonathan MD; Verheugt, Freek W.A. MD; Wildgoose, Peter PhD; Burton, Paul MD, PhD; van Eickels, Martin MD; Korjian, Serge MD; Daaboul, Yazan MD; Jain, Purva MPH; Lip, Gregory Y.H. MD; Cohen, Marc MD; Peterson, Eric D. MD, MPH; Fox, Keith A.A. MBChB

Page: 323-333

http://ift.tt/2jLeGTm